Georgia Erbez Appointed Chief Financial Officer Of Asterias Biotherapeutics
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Asterias Biotherapeutics (AST) Names New CFO
November 2, 2015 6:34 AM ESTAsterias Biotherapeutics (NYSE: AST) announced the appointment of Georgia Erbez to the position of Chief Financial Officer of the Company effective November 9, 2015. Ms. Erbez joins Asterias after serving as a financial consultant to numerous biotechnology companies and previously serving as Chief Financial Officer, Secretary, and Treasurer of Raptor Pharmaceutical Corp. She will report to Asterias's President & CEO Pedro Lichtinger and will be based at the Company's Menlo Park, California headquarters.
"After an extensive search for a financial executive with a broad range of experience and strategic acumen, we are delighted... More
